PPARG and obesity due to melanocortin 4 receptor deficiency: In this context, our data showing down-regulation of PPARG, AP2, LEP and TNFA mRNA levels by Braco-19 treatment of differentiating ASCs suggest that targeting G4 motif might be beneficial against obesity-associated excessive lipid accumulation and inflammation.